BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10833025)

  • 1. Identification of a new metabolite of macrolide immunosuppressant, like rapamycin and SDZ RAD, using high performance liquid chromatography and electrospray tandem mass spectrometry.
    Hallensleben K; Raida M; Habermehl G
    J Am Soc Mass Spectrom; 2000 Jun; 11(6):516-25. PubMed ID: 10833025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural elucidation by electrospray mass spectrometry: an approach to the in vitro metabolism of the macrolide immunosuppressant SDZ RAD.
    Vidal C; Kirchner GI; Sewing KF
    J Am Soc Mass Spectrom; 1998 Dec; 9(12):1267-74. PubMed ID: 9835072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro biotransformation of SDZ RAD: a new immunosuppressive macrolide in human liver microsomal preparations.
    Dannecker R; Vickers AE; Ubeaud G; Hauck C
    Transplant Proc; 1998 Aug; 30(5):2206. PubMed ID: 9723442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation from pig liver microsomes, identification by tandem mass spectrometry and in vitro immunosuppressive activity of an SDZ-RAD 17,18,19,20,21,22-tris-epoxide.
    Lhoëst GJ; Gougnard TY; Verbeeck RK; Maton N; Dehoux JP; Wallemacq P; Schüler W; Latinne D
    J Mass Spectrom; 2000 Mar; 35(3):454-60. PubMed ID: 10767777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment and validation of the MS/MS fragmentation patterns of the macrolide immunosuppressant everolimus.
    Boernsen KO; Egge-Jacobsen W; Inverardi B; Strom T; Streit F; Schiebel HM; Benet LZ; Christians U
    J Mass Spectrom; 2007 Jun; 42(6):793-802. PubMed ID: 17511017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro immunosuppressive activity of tacrolimus dihydrodiol precursors obtained by chemical oxidation and identification of a new metabolite of SDZ-RAD by electrospray and electrospray-linked scan mass spectrometry.
    Lhoëst G; Hertsens R; Verbeeck RK; Maton N; Wallemacq P; Dehoux JP; Latinne D
    J Mass Spectrom; 2001 Aug; 36(8):889-901. PubMed ID: 11523088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a high-performance liquid chromatographic-electrospray mass spectrometric assay for the specific and sensitive quantification of the novel immunosuppressive macrolide 40-O-(2-hydroxyethyl)rapamycin.
    Segarra I; Brazelton TR; Guterman N; Hausen B; Jacobsen W; Morris RE; Benet LZ; Christians U
    J Chromatogr B Biomed Sci Appl; 1998 Dec; 720(1-2):179-87. PubMed ID: 9892080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LC/ESI-MS allows simultaneous and specific quantification of SDZ RAD and cyclosporine, including groups of their metabolites in human blood.
    Kirchner GI; Vidal C; Winkler M; Mueller L; Jacobsen W; Franzke A; Sewing KF
    Ther Drug Monit; 1999 Feb; 21(1):116-22. PubMed ID: 10051064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro metabolic study of temsirolimus: preparation, isolation, and identification of the metabolites.
    Cai P; Tsao R; Ruppen ME
    Drug Metab Dispos; 2007 Sep; 35(9):1554-63. PubMed ID: 17540708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel immunosuppressant SDZ-RAD protects rat brain slices from cyclosporine-induced reduction of high-energy phosphates.
    Serkova N; Litt L; Leibfritz D; Hausen B; Morris RE; James TL; Benet LZ; Christians U
    Br J Pharmacol; 2000 Feb; 129(3):485-92. PubMed ID: 10711346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of SDZ RAD and cyclosporin including their metabolites in seven kidney graft patients after the first dose of SDZ RAD.
    Kirchner GI; Winkler M; Mueller L; Vidal C; Jacobsen W; Franzke A; Wagner S; Blick S; Manns MP; Sewing KF
    Br J Clin Pharmacol; 2000 Nov; 50(5):449-54. PubMed ID: 11069439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated simultaneous quantification of the immunosuppressants 40-O-(2-hydroxyethyl) rapamycin and cyclosporine in blood with electrospray-mass spectrometric detection.
    Vidal C; Kirchner GI; Wünsch G; Sewing KF
    Clin Chem; 1998 Jun; 44(6 Pt 1):1275-82. PubMed ID: 9625053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural identification of three metabolites and a degradation product of the macrolide immunosuppressant sirolimus (rapamycin) by electrospray-MS/MS after incubation with human liver microsomes.
    Streit F; Christians U; Schiebel HM; Meyer A; Sewing KF
    Drug Metab Dispos; 1996 Nov; 24(11):1272-8. PubMed ID: 8937863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue distribution and clinical monitoring of the novel macrolide immunosuppressant SDZ-RAD and its metabolites in monkey lung transplant recipients: interaction with cyclosporine.
    Serkova N; Hausen B; Berry GJ; Jacobsen W; Benet LZ; Morris RE; Christians U
    J Pharmacol Exp Ther; 2000 Jul; 294(1):323-32. PubMed ID: 10871329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in situ absorption of SDZ-RAD using a human intestinal cell line (Caco-2) and a single pass perfusion model in rats: comparison with rapamycin.
    Crowe A; Lemaire M
    Pharm Res; 1998 Nov; 15(11):1666-72. PubMed ID: 9833985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification and stability of everolimus (SDZ RAD) in human blood by high-performance liquid chromatography-electrospray tandem mass spectrometry.
    Salm P; Taylor PJ; Lynch SV; Pillans PI
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jun; 772(2):283-90. PubMed ID: 12007773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation from pig liver microsomes, identification by electrospray tandem mass spectrometry and in vitro immunosuppressive activity of a rapamycin tris-epoxide metabolite.
    Lhoëst G; Zey T; Verbeeck RK; Wallemacq P; Maton N; De Houx JP; Latinne D
    J Mass Spectrom; 1999 Jan; 34(1):28-32. PubMed ID: 10028689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption and intestinal metabolism of SDZ-RAD and rapamycin in rats.
    Crowe A; Bruelisauer A; Duerr L; Guntz P; Lemaire M
    Drug Metab Dispos; 1999 May; 27(5):627-32. PubMed ID: 10220493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of performance of new, isotopically labeled internal standard ([13c2d4]RAD001) for everolimus using a novel high-performance liquid chromatography tandem mass spectrometry method.
    Korecka MA; Patel R; Shaw LM
    Ther Drug Monit; 2011 Aug; 33(4):460-3. PubMed ID: 21743385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and identification of a C39 demethylated metabolite of rapamycin from pig liver microsomes and evaluation of its immunosuppressive activity.
    Nickmilder MJ; Latinne D; De Houx JP; Verbeeck RK; Lhoëst GJ
    Clin Chem; 1998 Mar; 44(3):532-8. PubMed ID: 9510858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.